Wiederschain; Dmitri G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wiederschain; Dmitri G..The latest application filed is for "therapeutic rna".

Company Profile

0.5.7

Wiederschain; Dmitri G. - Bridgewater NJ
Wiederschain; Dmitri G. - Cambridge MA
Wiederschain; Dmitri G. - Brighton MA
Wiederschain; Dmitri G. - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic RNA App 20210290730 - Gieseke; Friederike ; et al.	2021-09-23
Therapeutic RNA App 20200147176 - Gieseke; Friederike ; et al.	2020-05-14
Methods Of Inhibiting Angiogenesis With Fragments And Homologs Of Troponin Subunit I App 20090156491 - Thorn; Richard M. ; et al.	2009-06-18
Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1 Grant 7,452,866 - Thorn , et al. November 18, 2	2008-11-18
Pharmaceutical compositions comprising fragments and homologs of troponin subunits Grant 7,393,829 - Moses , et al. July 1, 2	2008-07-01
Pharmaceutical compositions comprising fragments and homologs of troponin subunits App 20080051345 - Moses; Marsha A. ; et al.	2008-02-28
Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1 App 20060211614 - Thorn; Richard M. ; et al.	2006-09-21
Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I Grant 7,078,385 - Thorn , et al. July 18, 2	2006-07-18
Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I App 20030186864 - Thorn, Richard M. ; et al.	2003-10-02
Pharmaceutical compositions comprising recombinant troponin subunits Grant 6,589,936 - Thorn , et al. July 8, 2	2003-07-08
Pharmaceutical compositions comprising fragments and homologs of troponin subunits App 20030083255 - Thorn, Richard M. ; et al.	2003-05-01
Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis Grant 6,465,431 - Thorn , et al. October 15, 2	2002-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.